Molecular Neurodegeneration

Molecular Neurodegeneration (MN) is an open access, peer-reviewed journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels https://molecularneurodegeneration.biomedcentral.com/). The current Editors-In-Chief are Guojun Bu, PhD, Mayo Clinic, USA, and Huaxi Xu, PhD, Sanford Burnham Prebys Medical Discovery Institute, USA. MN is the official journal of the BrightFocus Foundation (http://www.brightfocus.org/research/molecular-neurodegeneration-journal). The open access publishing model provides free articles to the general public, as well as scientists, clinicians, and other healthcare practitioners. MN publishes peer-reviewed, original scientific research on the causes of neurodegenerative diseases, such as Alzheimer’s or Parkinson’ and on the pre-clinical testing of potential therapies for these devastating diseases. In 2016, MN has an impact score of 6.56., meaning the journal is now the highest ranking open access neuroscience journal in the journal citation reports (JCR).